CIK 0001783183 · Non-accelerated filer<br>Smaller reporting company
Phathom Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PHAT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 824151574
- Phone
- (877) 742-8466
- Business address
- 100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-03 | Breedlove Robert Charles Principal Accounting Officer | Sale | −524 | $13.51 | $7K | 47,407 |
| 2025-09-05 | Breedlove Robert Charles Principal Accounting Officer | Sale | −461 | $12.09 | $6K | 47,931 |
| 2025-07-16 | Breedlove Robert Charles Principal Accounting Officer | Sale | −1,692 | $8.36 | $14K | 48,392 |
| 2025-04-07 | Henderson Molly CFO and CBO | Sale | −3,678 | $4.55 | $17K | 89,868 |
| 2025-01-21 | Henderson Molly CFO and CBO | Sale | −6,583 | $6.59 | $43K | 93,546 |
| 2025-01-21 | Nabulsi Azmi Chief Operating Officer | Sale | −7,886 | $6.59 | $52K | 233,390 |
| 2025-01-21 | Curran Terrie President and Chief Executive | Sale | −19,109 | $6.59 | $126K | 360,465 |
| 2024-12-19 | Nabulsi Azmi Chief Operating Officer | Sale | −1,118 | $8.00 | $9K | 239,303 |
| 2024-12-19 | Henderson Molly CFO and CBO | Sale | −1,291 | $8.00 | $10K | 98,156 |
| 2024-07-15 | Nabulsi Azmi Chief Operating Officer | Sale | −10,901 | $11.72 | $128K | 240,421 |
| 2024-07-15 | Henderson Molly CFO and CBO | Sale | −4,325 | $11.72 | $51K | 99,447 |
| 2024-07-15 | Curran Terrie President and Chief Executive | Sale | −33,848 | $11.72 | $397K | 377,734 |
| 2024-04-08 | Henderson Molly CFO and CBO | Sale | −3,435 | $11.10 | $38K | 95,263 |
| 2024-03-22 | Curran Terrie President and Chief Executive | Sale | −16,851 | $9.11 | $154K | 410,784 |
| 2024-01-24 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Sale | −3,703,703 | $8.10 | $30.0M | 3,755,583 |
| 2024-01-19 | Henderson Molly CFO and CBO | Sale | −6,307 | $7.75 | $49K | 98,698 |
| 2023-11-20 | Henderson Molly CFO and CBO | Sale | −2,127 | $7.24 | $15K | 103,061 |
| 2023-11-01 | Henderson Molly CFO and CBO | Sale | −811 | $7.80 | $6K | 116,869 |
| 2023-11-01 | Henderson Molly CFO and CBO | Sale | −11,681 | $8.95 | $105K | 105,188 |
| 2023-06-02 | Henderson Molly CFO and CBO | Sale 10b5-1 | −1,960 | $11.41 | $22K | 68,506 |
Page 1 of 9 · 166 trades